Notrox Research Private Limited logo

Notrox Research Private Limited

Provides pharmaceutical research and development services, including clinical and bio analytical testing.
2014 | Bangaluru, Karnataka (India) | Active

Last Updated:

January 11, 2025
HomeCompanyNotrox Research Private Limited

Who are the key members and board of directors at Notrox Research?

Board Members(2)

NameDesignationAppointment DateStatus
Hanumanthappa Kumar In Director 23-May-2014Current
Bangalore Shanthala In Director 23-May-2014Current

Financial Performance of Notrox Research.

Notrox Research Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 4.1% decrease. The company also saw a substantial fall in profitability, with a 14.71% decrease in profit. The company's net worth Soared by an impressive increase of 28.65%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-4.10%
Revenue from Operations
-0.83%
Total Assets
43.45%
Profit or Loss
-14.71%
Net Worth
28.65%
EBITDA
-2.98%

Charges (Loans)

Charges

There are no open charges registered against the company as per our records.

How Many Employees Work at Notrox Research?

Notrox Research has a workforce of 30 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Notrox Research

Recent activity within the organization

  • Annual General Meeting

    Notrox Research Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Notrox Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.

    31 Mar 2024

  • Director Appointment

    Hanumanthappa Basavahanalli Anil Kumar was appointed as a Director was appointed as a Director on 23 May 2014 & has been associated with this company since 10 years 7 months .

    23 May 2014

  • Director Appointment

    Bangalore Prakash Shanthala was appointed as a Director was appointed as a Director on 23 May 2014 & has been associated with this company since 10 years 7 months .

    23 May 2014

  • Company Incorporation

    Notrox Research Private Limited was registered on 23 May 2014 with Roc Bangalore & aged 10 years 7 months as per MCA records.

    23 May 2014

Frequently asked questions

  • Notrox Research Private Limited was incorporated on 23 May 2014.

  • The authorized share capital of Notrox Research Private Limited is ₹ 2.00 Cr and paid-up capital is ₹ 5.00 M.

  • Currently 2 directors are associated with Notrox Research Private Limited.

    • Hanumanthappa Basavahanalli Anil Kumar
    • Bangalore Prakash Shanthala
  • As per Ministry of Corporate Affairs (Mca), the registered address of Notrox Research Private Limited is 2Nd Floor Survey No.19/3, Bikasipura Road Off Kanakapura (Behind Metro Cash Carry) India, Bangalore, Karnataka, 560062.

  • The corporate identification number (CIN) of Notrox Research Private Limited is U73100KA2014PTC074596 and the company number is 074596 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Notrox Research Private Limited is https://www.notroxresearch.com

  • According to the financial reports for the fiscal year 2021, the revenue trend for Notrox Research Private Limited has fallen by -4.10%.

  • As Per 2021 financial reports, 30 employees are currently employed by Notrox Research Private Limited.

  • The financial reports for the fiscal year 2021 indicates that The net worth of Notrox Research Private Limited has experienced an upsurge of 28.65%.

  • The most recent Balance Sheet for Notrox Research Private Limited was filed with the ROC on 31 Mar 2024.

Similar Companies Based on Pharma Contract R&D